Literature DB >> 21555454

The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3.

Shaila Rahman1, Mathew E Sowa, Matthias Ottinger, Jennifer A Smith, Yang Shi, J Wade Harper, Peter M Howley.   

Abstract

Bromodomain protein 4 (Brd4) plays critical roles in development, cancer progression, and virus-host pathogenesis. To gain mechanistic insight into the various biological functions of Brd4, we performed a proteomic analysis to identify and characterize Brd4-associated cellular proteins. We found that the extraterminal (ET) domain, whose function has to date not been determined, interacts with NSD3, JMJD6, CHD4, GLTSCR1, and ATAD5. These ET-domain interactions were also conserved for Brd2 and Brd3, the other human BET proteins tested. We demonstrated that GLTSCR1, NSD3, and JMJD6 impart a pTEFb-independent transcriptional activation function on Brd4. NSD3 as well as JMJD6 is recruited to regulated genes in a Brd4-dependent manner. Moreover, we found that depletion of Brd4 or NSD3 reduces H3K36 methylation, demonstrating that the Brd4/NSD3 complex regulates this specific histone modification. Our results indicate that the Brd4 ET domain through the recruitment of the specific effectors regulates transcriptional activity. In particular, we show that one of these effectors, NSD3, regulates transcription by modifying the chromatin microenvironment at Brd4 target genes. Our study thus identifies the ET domain as a second important transcriptional regulatory domain for Brd4 in addition to the carboxyl-terminal domain (CTD) that interacts with pTEFb.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555454      PMCID: PMC3133372          DOI: 10.1128/MCB.01341-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19).

Authors:  C A French; I Miyoshi; J C Aster; I Kubonishi; T G Kroll; P Dal Cin; S O Vargas; A R Perez-Atayde; J A Fletcher
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

Authors:  Roberto Rosati; Roberta La Starza; Angelo Veronese; Ana Aventin; Christine Schwienbacher; Teresa Vallespi; Massimo Negrini; Massimo F Martelli; Cristina Mecucci
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

3.  The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.

Authors:  Gary LeRoy; Brenden Rickards; S J Flint
Journal:  Mol Cell       Date:  2008-04-11       Impact factor: 17.970

4.  Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4.

Authors:  Denis Houzelstein; Simon L Bullock; Denise E Lynch; Elena F Grigorieva; Valerie A Wilson; Rosa S P Beddington
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

5.  Bromodomain factor 1 corresponds to a missing piece of yeast TFIID.

Authors:  O Matangkasombut; R M Buratowski; N W Swilling; S Buratowski
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

6.  Bromodomain 4 activation predicts breast cancer survival.

Authors:  Nigel P S Crawford; Jude Alsarraj; Luanne Lukes; Renard C Walker; Jennifer S Officewala; Howard H Yang; Maxwell P Lee; Keiko Ozato; Kent W Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

7.  JMJD6 is a histone arginine demethylase.

Authors:  Bingsheng Chang; Yue Chen; Yingming Zhao; Richard K Bruick
Journal:  Science       Date:  2007-10-19       Impact factor: 47.728

8.  The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.

Authors:  Ammy Lin; Shan Wang; Tin Nguyen; Kathy Shire; Lori Frappier
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

9.  Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.

Authors:  Won-Kyung Cho; Meisheng Zhou; Moon Kyoo Jang; Keven Huang; Soo-Jin Jeong; Keiko Ozato; John N Brady
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

10.  BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.

Authors:  C A French; C L Ramirez; J Kolmakova; T T Hickman; M J Cameron; M E Thyne; J L Kutok; J A Toretsky; A K Tadavarthy; U R Kees; J A Fletcher; J C Aster
Journal:  Oncogene       Date:  2007-10-15       Impact factor: 9.867

View more
  241 in total

Review 1.  Understanding the language of Lys36 methylation at histone H3.

Authors:  Eric J Wagner; Phillip B Carpenter
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-23       Impact factor: 94.444

2.  Diverse epigenetic strategies interact to control epidermal differentiation.

Authors:  Klaas W Mulder; Xin Wang; Carles Escriu; Yoko Ito; Roland F Schwarz; Jesse Gillis; Gábor Sirokmány; Giacomo Donati; Santiago Uribe-Lewis; Paul Pavlidis; Adele Murrell; Florian Markowetz; Fiona M Watt
Journal:  Nat Cell Biol       Date:  2012-06-24       Impact factor: 28.824

3.  Integrated cross-species transcriptional network analysis of metastatic susceptibility.

Authors:  Ying Hu; Gang Wu; Michael Rusch; Luanne Lukes; Kenneth H Buetow; Jinghui Zhang; Kent W Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

4.  Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.

Authors:  Gustavo Martínez-Noël; Jeffrey T Galligan; Mathew E Sowa; Verena Arndt; Thomas M Overton; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 5.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

6.  Structure of the Brd4 ET domain bound to a C-terminal motif from γ-retroviral integrases reveals a conserved mechanism of interaction.

Authors:  Brandon L Crowe; Ross C Larue; Chunhua Yuan; Sonja Hess; Mamuka Kvaratskhelia; Mark P Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

7.  Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.

Authors:  Beatriz Suarez-Alvarez; José Luis Morgado-Pascual; Sandra Rayego-Mateos; Ramon M Rodriguez; Raul Rodrigues-Diez; Pablo Cannata-Ortiz; Ana B Sanz; Jesus Egido; Pierre-Louis Tharaux; Alberto Ortiz; Carlos Lopez-Larrea; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

8.  Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement.

Authors:  Surojeet Sengupta; Michael C Biarnes; Robert Clarke; V Craig Jordan
Journal:  Breast Cancer Res Treat       Date:  2015-02-27       Impact factor: 4.872

Review 9.  BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.

Authors:  Patricia Cristine Borck; Lian-Wang Guo; Jorge Plutzky
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

10.  Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.

Authors:  Surya Nagaraja; Nicholas A Vitanza; Pamelyn J Woo; Kathryn R Taylor; Fang Liu; Lei Zhang; Meng Li; Wei Meng; Anitha Ponnuswami; Wenchao Sun; Jie Ma; Esther Hulleman; Tomek Swigut; Joanna Wysocka; Yujie Tang; Michelle Monje
Journal:  Cancer Cell       Date:  2017-04-20       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.